Emergent BioSolutions (EBS) Return on Invested Capital (2012 - 2021)
Emergent BioSolutions (EBS) posted quarterly Return on Invested Capital of 0.18% for Q1 2021, up 17.0% year-over-year from 0.15% in Q1 2020, and up 33.9% quarter-over-quarter from 0.13% in Q4 2020.
Emergent BioSolutions (EBS) Return on Invested Capital (2012 - 2021) Analysis & Trends
Emergent BioSolutions' Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.18% for Q1 2021.
- In Q1 2021, Return on Invested Capital rose 17.0% year-over-year to 0.18%; the TTM figure through Mar 2021 stood at 0.18% (up 17.0% YoY), while the FY2019 annual figure was 0.18%, changed N/A from the prior year.
- Return on Invested Capital for Q1 2021 stood at 0.18%, up from 0.13% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.18% in Q1 2021, with the low at 0.0% in Q2 2019.
- The 3-year median for Return on Invested Capital is 0.02% (2019), against an average of 0.04%.
- The sharpest annual moves came in 2020 and 2021: Return on Invested Capital decreased 1 bps in 2020, then grew 17 bps in 2021.
- Emergent BioSolutions' Return on Invested Capital stood at 0.0% in 2019, then surged by 2874 bps to 0.13% in 2020, then jumped by 34 bps to 0.18% in 2021.
- Business Quant data shows EBS's Return on Invested Capital at 0.18% in Q1 2021, 0.13% in Q4 2020, and 0.04% in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 0.18% |
| Dec 31, 2020 | 0.13% |
| Sep 30, 2020 | 0.04% |
| Jun 30, 2020 | 0.02% |
| Mar 31, 2020 | 0.01% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.02% |
| Jun 30, 2014 | 0.05% |
| Mar 31, 2014 | 0.03% |
| Dec 31, 2013 | 0.03% |
| Sep 30, 2013 | 0.02% |
| Jun 30, 2013 | 0.01% |
| Mar 31, 2013 | 0.01% |
| Dec 31, 2012 | 0.01% |
| Sep 30, 2012 | 0.02% |
| Jun 30, 2012 | 0.01% |
| Mar 31, 2012 | 0.01% |